Heartflow, Inc. Chief Medical Officer Campbell Rogers filed a Form 4 on November 10, 2026, disclosing a disposition of 2,270 shares of common stock on November 6, 2026, related to restricted stock unit vesting and tax withholding.
Key Highlights
- Reporting person: Campbell Rogers, Chief Medical Officer of Heartflow, Inc. (NASDAQ:HTFL)
- Transaction: 2,270 shares of common stock disposed of on November 6, 2026, via transaction code F at a price of $52.4 per share
- Purpose: According to the filing, the shares were "retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported"
- Direct holdings after transaction: 71,183 shares of common stock held directly
- Indirect holdings: An additional 145,540 shares held indirectly across four trusts
- Filing signed: By Nga Van, by power of attorney, on November 10, 2026
Rogers' RSU Tax Withholding and Beneficial Ownership at Heartflow
According to the Form 4 filed with the SEC, Campbell Rogers, serving as Chief Medical Officer of Heartflow, Inc. (NASDAQ:HTFL), reported a single non-derivative transaction dated November 6, 2026. The transaction code F indicates that 2,270 shares of common stock were disposed of at a price of $52.4 per share. The filing states these shares were retained by the issuer to cover income tax withholding obligations arising from the vesting and net settlement of restricted stock units that had been previously reported.
Following the reported transaction, Rogers directly beneficially owned 71,183 shares of Heartflow common stock. The filing also discloses four categories of indirect beneficial ownership: 22,615 shares held by the Campbell Rogers 2019 Irrevocable Trust, 46,159 shares held by the CR Asset Protection Trust of 2023, 26,012 shares held by a Spouse's Trust, and 50,754 shares held by The Campbell Rogers Revocable Trust. These four indirect holdings total 145,540 shares.
The Form 4 was filed on November 10, 2026, with November 6, 2026, listed as the date of the earliest transaction. The document was signed by Nga Van acting under a power of attorney on behalf of the reporting person.
What Was Disclosed
Campbell Rogers, Chief Medical Officer of Heartflow, Inc., disclosed a disposition of 2,270 shares at $52.4 each on November 6, 2026, solely to satisfy RSU-related tax withholding obligations, leaving direct beneficial ownership of 71,183 shares and indirect ownership of 145,540 shares across four trusts.



Please wait processing your request...